Advanced

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

Kooij, J. J.S.; Bijlenga, D.; Salerno, L.; Jaeschke, R.; Bitter, I.; Balázs, J.; Thome, J.; Dom, G.; Kasper, S. and Nunes Filipe, C., et al. (2019) In European Psychiatry 56. p.14-34
Abstract

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of... (More)

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adult ADHD, Diagnosis, EPA, European Network Adult ADHD, Treatment, Updated European Consensus Statement
in
European Psychiatry
volume
56
pages
21 pages
publisher
Elsevier Masson SAS
external identifiers
  • scopus:85056845323
  • scopus:85056845323
ISSN
0924-9338
DOI
10.1016/j.eurpsy.2018.11.001
language
English
LU publication?
yes
id
c3436464-2d37-4d9c-a1bc-cb17ea62db75
date added to LUP
2019-06-14 10:40:35
date last changed
2019-09-22 05:02:55
@article{c3436464-2d37-4d9c-a1bc-cb17ea62db75,
  abstract     = {<p>Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.</p>},
  author       = {Kooij, J. J.S. and Bijlenga, D. and Salerno, L. and Jaeschke, R. and Bitter, I. and Balázs, J. and Thome, J. and Dom, G. and Kasper, S. and Nunes Filipe, C. and Stes, S. and Mohr, P. and Leppämäki, S. and Casas Brugué, M. and Bobes, J. and Mccarthy, J. M. and Richarte, V. and Kjems Philipsen, A. and Pehlivanidis, A. and Niemela, A. and Styr, B. and Semerci, B. and Bolea-Alamanac, B. and Edvinsson, D. and Baeyens, D. and Wynchank, D. and Sobanski, E. and Philipsen, A. and McNicholas, F. and Caci, H. and Mihailescu, I. and Manor, I. and Dobrescu, I. and Krause, J. and Fayyad, J. and Ramos-Quiroga, J. A. and Foeken, K. and Rad, F. and Adamou, M. and Ohlmeier, M. and Fitzgerald, M. and Gill, M. and Lensing, M. and Motavalli Mukaddes, N. and Brudkiewicz, P. and Gustafsson, P. and Tani, P. and Oswald, P. and Carpentier, P. J. and De Rossi, P.},
  issn         = {0924-9338},
  keyword      = {Adult ADHD,Diagnosis,EPA,European Network Adult ADHD,Treatment,Updated European Consensus Statement},
  language     = {eng},
  month        = {02},
  pages        = {14--34},
  publisher    = {Elsevier Masson SAS},
  series       = {European Psychiatry},
  title        = {Updated European Consensus Statement on diagnosis and treatment of adult ADHD},
  url          = {http://dx.doi.org/10.1016/j.eurpsy.2018.11.001},
  volume       = {56},
  year         = {2019},
}